Credit Industriel ET Commercial Makes New Investment in Amedisys, Inc. (NASDAQ:AMED)

Credit Industriel ET Commercial acquired a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 38,399 shares of the health services provider's stock, valued at approximately $3,486,000. Amedisys makes up approximately 0.5% of Credit Industriel ET Commercial's holdings, making the stock its 28th biggest position. Credit Industriel ET Commercial owned 0.12% of Amedisys at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Blue Trust Inc. raised its position in Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after purchasing an additional 124 shares during the period. HBW Advisory Services LLC purchased a new position in shares of Amedisys in the fourth quarter worth $38,000. Versant Capital Management Inc raised its holdings in Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock valued at $41,000 after buying an additional 183 shares during the last quarter. Vestcor Inc purchased a new stake in Amedisys during the 4th quarter valued at $73,000. Finally, Venturi Wealth Management LLC grew its holdings in Amedisys by 397.4% in the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after acquiring an additional 779 shares during the last quarter. 94.36% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

AMED has been the topic of several recent analyst reports. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 target price on shares of Amedisys in a research note on Wednesday, April 16th. Stephens restated an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a report on Tuesday, March 4th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, Amedisys has an average rating of "Hold" and an average price target of $100.75.

Amedisys Stock Down 0.0 %

Shares of AMED stock traded down $0.01 during midday trading on Tuesday, reaching $94.68. 218,128 shares of the stock were exchanged, compared to its average volume of 405,458. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95. The firm has a market cap of $3.11 billion, a PE ratio of 37.59, a price-to-earnings-growth ratio of 1.78 and a beta of 0.89. The company's 50 day moving average is $92.25 and its two-hundred day moving average is $91.74. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $594.78 million during the quarter, compared to the consensus estimate of $597.43 million. During the same quarter in the prior year, the company earned $1.03 earnings per share. The firm's quarterly revenue was up 4.1% compared to the same quarter last year. On average, equities research analysts predict that Amedisys, Inc. will post 4.4 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.